» Articles » PMID: 37245871

Network Pharmacology Approaches for Research of Traditional Chinese Medicines

Overview
Journal Chin J Nat Med
Publisher Science Press
Date 2023 May 28
PMID 37245871
Authors
Affiliations
Soon will be listed here.
Abstract

Pharmacodynamics material basis and effective mechanisms are the two main issues to decipher the mechnisms of action of Traditional Chinese medicines (TCMs) for the treatment of diseases. TCMs, in "multi-component, multi-target, multi-pathway" paradigm, show satisfactory clinical results in complex diseases. New ideas and methods are urgently needed to explain the complex interactions between TCMs and diseases. Network pharmacology (NP) provides a novel paradigm to uncover and visualize the underlying interaction networks of TCMs against multifactorial diseases. The development and application of NP has promoted the safety, efficacy, and mechanism investigations of TCMs, which then reinforces the credibility and popularity of TCMs. The current organ-centricity of medicine and the "one disease-one target-one drug" dogma obstruct the understanding of complex diseases and the development of effective drugs. Therefore, more attentions should be paid to shift from "phenotype and symptom" to "endotype and cause" in understanding and redefining current diseases. In the past two decades, with the advent of advanced and intelligent technologies (such as metabolomics, proteomics, transcriptomics, single-cell omics, and artificial intelligence), NP has been improved and deeply implemented, and presented its great value and potential as the next drug-discovery paradigm. NP is developed to cure causal mechanisms instead of treating symptoms. This review briefly summarizes the recent research progress on NP application in TCMs for efficacy research, mechanism elucidation, target prediction, safety evaluation, drug repurposing, and drug design.

Citing Articles

The Extract of Improves the Cognitive Impairment and Mood in Sleep-Deprived Mice Through the JAK1/STAT3 Signalling Pathway.

Guan D, Hou Z, Fan B, Bai Y, Wu H, Yu J Int J Mol Sci. 2025; 26(5).

PMID: 40076470 PMC: 11899911. DOI: 10.3390/ijms26051842.


Network pharmacology and study: Unraveling the therapeutic mechanisms of in potentially treating ulcerative colitis.

Qin Y, Zhang R, Zhang Y, Zhao Y, Hao H, Wang J World J Gastroenterol. 2025; 31(9):100271.

PMID: 40061598 PMC: 11886041. DOI: 10.3748/wjg.v31.i9.100271.


Uncovering the mechanism of Huangkui capsule in the treatment of diabetic kidney disease based on network pharmacology and experimental validation.

Liu J, Li Z, Zhang Z, Shen Z Sci Rep. 2025; 15(1):6503.

PMID: 39987179 PMC: 11846948. DOI: 10.1038/s41598-025-91264-w.


Combining network pharmacology and molecular docking to explore the pharmacological mechanism of Codonopsis Radix.-Hedysarum Multijugum Maxim.-Atractylodes Macrocephala Koidz. in treating lung cancer.

He B, Cui J, Zhang Z, Zhang Y BMC Complement Med Ther. 2025; 25(1):66.

PMID: 39984956 PMC: 11846413. DOI: 10.1186/s12906-025-04823-z.


Anti-cystitis glandularis action exerted by glycyrrhetinic acid: bioinformatics analysis and molecular validation.

Hu H, Tang Y, Zhou B, Chen S, Su J, Zhong W Mol Divers. 2025; .

PMID: 39873885 DOI: 10.1007/s11030-025-11105-w.